Publication | Open Access
Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trial
49
Citations
16
References
2023
Year
KeyMed Biosciences (Chengdu) Limited.
| Year | Citations | |
|---|---|---|
Page 1
Page 1